Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)
EPOCH-RRT
1 other identifier
observational
215
1 country
1
Brief Summary
The EPOCH-RRT study seeks to fill knowledge gaps by gaining more understanding of chronic kidney disease (CKD) patients' priorities; assessing the comparative benefits of hemodialysis (HD) versus peritoneal dialysis (PD), with respect to these priorities; and providing tailored information to assist patients with identifying the best dialysis modality fit for their own unique circumstances and perspectives. The outcomes most relevant to patients ("patient-centered") extend beyond those traditionally assessed in clinical research, with the relative importance varying across patient groups. A tailored decision aid based on these findings can improve patient decision-making processes regarding choice of dialysis modality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 28, 2013
CompletedFirst Posted
Study publicly available on registry
September 30, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedResults Posted
Study results publicly available
August 8, 2016
CompletedSeptember 20, 2016
August 1, 2016
6 months
June 28, 2013
June 24, 2016
August 10, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Factors That Are Most Important to Patients
Differences in factors most important to patients were compared across chronic kidney disease, hemodialysis, and peritoneal dialysis patients.
Baseline
Study Arms (3)
Chronic Kidney Disease (CKD)
Patients who have advanced chronic kidney disease, but are not currently on either hemodialysis (HD) or peritoneal dialysis (PD).
Hemodialysis (HD)
Patients who have chronic kidney disease (CKD) and are currently on hemodialysis.
Peritoneal Dialysis (PD)
Patients who have chronic kidney disease (CKD) and are currently on peritoneal dialysis.
Eligibility Criteria
Adult patients residing in the United States with advanced chronic kidney disease or on dialysis.
You may qualify if:
- Individuals 18 years of age or older.
- Individuals with advanced chronic kidney disease or on dialysis (in-center, hemodialysis, or peritoneal dialysis) for at least three months.
You may not qualify if:
- Individuals under 18 years of age.
- Individuals unable to provide informed consent.
- Individuals who do not have chronic kidney disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arbor Research Collaborative for Healthlead
- University of Michigancollaborator
- Henry Ford Health Systemcollaborator
- National Kidney Foundation, United Statescollaborator
- American Association of Kidney Patientscollaborator
- Patient-Centered Outcomes Research Institutecollaborator
Study Sites (1)
Arbor Research Collaborative for Health
Ann Arbor, Michigan, 48104, United States
Related Links
- Arbor Research Collaborative for Health is committed to improving patient care through research that shapes medical policies and practice.
- The University of Michigan Division of Nephrology is internationally recognized for its excellence in clinical care, rich educational offerings, and diverse research programs.
- University of Michigan Center for Managing Chronic Disease aims to build the capacity for effective chronic disease prevention and management.
- The National Kidney Foundation is a voluntary nonprofit health organization dedicated to preventing kidney disease.
- The American Association of Kidney Patients is dedicated to improving the lives of kidney patients and their families by helping them deal with the physical, emotional, and social impact of kidney disease.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Francesca Tentori
- Organization
- Arbor Research Collaborative for Health
Study Officials
- PRINCIPAL INVESTIGATOR
Francesca Tentori, MD, MS
Arbor Research Collaborative for Health
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2013
First Posted
September 30, 2013
Study Start
June 1, 2013
Primary Completion
December 1, 2013
Study Completion
December 1, 2015
Last Updated
September 20, 2016
Results First Posted
August 8, 2016
Record last verified: 2016-08